The Clinical Impact of Comprehensive cfDNA Genomic Testing in Lung Cancer

被引：0
|
作者：
Geva, S. [1 ]
Rozenblum, A. Belilovski [1 ]
Twito, T. [2 ]
Grinberg, R. [3 ]
Dvir, A. [2 ]
Gutman, L. Soussan [2 ]
Roisman, L. [4 ]
Ilouze, M. [1 ]
Dudnik, E. [1 ]
Zer, A. [1 ]
Rotem, O. [1 ]
Lanman, R. [5 ]
Peled, N. [3 ]
机构：
[1] Rabin Med Ctr, Davidoff Canc Ctr, Thorac Canc Serv, Petah Tiqwa, Israel
[2] Oncotest Teva Pharmaceut Ltd, Petah Tiqwa, Israel
[3] Ben Gurion Univ Negev, Soroka Med Ctr, Beer Sheva, Israel
[4] Soroka Univ, Canc Inst, Med Ctr, Beer Sheva, Israel
[5] Guardant Hlth, Redwood City, CA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
liquid biopsy; non-small cell lung cancer; next generation sequencing;
D O I：
10.1016/j.jtho.2018.08.1588
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.01-28
引用
收藏
页码：S878 / S878
页数：1
相关论文
共 50 条
  • [31] Clinical outcomes for plasma-based comprehensive genomic profiling versus tissue testing in advanced lung adenocarcinoma.
    Page, Ray D.
    Drusbosky, Leylah
    Dada, Hiba I.
    Raymond, Victoria M.
    Daniel, Davey B.
    Divers, Stephen G.
    Reckamp, Karen L.
    Villalona-Calero, Miguel Angel
    Odegaard, Justin Iver
    Lanman, Richard B.
    Papadimitrakopoulou, Vassiliki
    Leighl, Natasha B.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [32] Comparison of Two Testing Methodologies for EGFR Mutation Screening of cfDNA from Lung Cancer Patients
    Sundstrom, M.
    Moens, L. N.
    Kraft, A.
    Garvin, S.
    Hallbeck, M.
    Sandberg, I.
    Vikstrom, A.
    Botling, J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (02): : S38 - S39
  • [33] Prognostic impact of cancer genomic profile testing for advanced or metastatic solid tumors in clinical practice
    Fukada, Ippei
    Mori, Seiichi
    Hayashi, Naomi
    Hosonaga, Mari
    Xiaofei, Wang
    Yamazaki, Masumi
    Ueki, Arisa
    Kiyotani, Kazuma
    Tonooka, Akiko
    Takeuchi, Kengo
    Ueno, Takayuki
    Takahashi, Shunji
    CANCER SCIENCE, 2023, 114 (12) : 4632 - 4642
  • [34] Genomic Testing and Therapies for Breast Cancer in Clinical Practice
    Haas, Jennifer S.
    Phillips, Kathryn A.
    Liang, Su-Ying
    Hassett, Michael J.
    Keohane, Carol
    Elkin, Elena B.
    Armstrong, Joanne
    Toscano, Michele
    AMERICAN JOURNAL OF MANAGED CARE, 2011, 17 (05): : E174 - E181
  • [35] Genomic Testing and Therapies for Breast Cancer in Clinical Practice
    Haas, Jennifer S.
    Phillips, Kathryn A.
    Liang, Su-Ying
    Hassett, Michael J.
    Keohane, Carol
    Elkin, Elena B.
    Armstrong, Joanne
    Toscano, Michele
    JOURNAL OF ONCOLOGY PRACTICE, 2011, 7 (03) : E1S - E7S
  • [36] Clinical implications of breast cancer tumor genomic testing
    Damodaran, Senthil
    Sember, Quinne C.
    Arun, Banu K.
    BREAST JOURNAL, 2020, 26 (08): : 1565 - 1571
  • [37] Evaluation of Patient Demographics in Clinical Cancer Genomic Testing
    Winston-McPherson, Gabrielle N.
    Mathias, Patrick C.
    Lockwood, Christina M.
    Greene, Dina N.
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2021, 6 (01): : 119 - 124
  • [38] Circulating Cell-Free Tumor DNA (cfDNA) Testing in Small Cell Lung Cancer
    Morgensztern, Daniel
    Devarakonda, Siddhartha
    Masood, Ashiq
    Waqar, Saiama
    Carmack, Alicia
    Banks, Kimberly
    Lanman, Richard
    Govindan, Ramaswamy
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S717 - S718
  • [39] Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May Benefit From Enrollment in Mechanism-Driven Clinical Trials
    Suh, James H.
    Johnson, Adrienne
    Albacker, Lee
    Wang, Kai
    Chmielecki, Juliann
    Frampton, Garrett
    Gay, Laurie
    Elvin, Julia A.
    Vergilio, Jo-Anne
    Ali, Siraj
    Miller, Vincent A.
    Stephens, Philip J.
    Ross, Jeffrey S.
    ONCOLOGIST, 2016, 21 (06): : 684 - 691
  • [40] Clinical impact of a cancer genomic profiling test using an in-house comprehensive targeted sequencing system
    Hayashi, Hideyuki
    Tanishima, Shigeki
    Fujii, Kyoko
    Mori, Ryo
    Okada, Chihiro
    Yanagita, Emmy
    Shibata, Yuka
    Matsuoka, Ryosuke
    Amano, Toraji
    Yamada, Takahiro
    Yabe, Ichiro
    Kinoshita, Ichiro
    Komatsu, Yoshito
    Dosaka-Akita, Hirotoshi
    Nishihara, Hiroshi
    CANCER SCIENCE, 2020, 111 (10) : 3926 - 3937
12345